Harris Williams advises Cold Chain Technologies on its pending sale

CCT develops innovative and differentiated packaging solutions

0
60
Cold Chain Technologies
Harris Williams advises Cold Chain Technologies on its pending sale to Aurora Capital Partners

Harris Williams, a global investment bank specializing in M&A advisory services, has announced that it is advising Cold Chain Technologies (CCT) on its pending sale to Aurora Capital Partners (Aurora). CCT claims to be a leading global provider of reusable and single-use passive thermal packaging solutions for the shipment of temperature-sensitive materials, principally serving the life sciences supply chain. CCT’s products are used in many segments of the life sciences industry, including commercial manufacturing, clinical trials, specialty pharmacy compliance and direct-to-patient shipments. The transaction is being led by Paul Hepper, Cheairs Porter, Ben Bloomfield, Nathan Robertson and Zach Prohaska of the Harris Williams Healthcare and Life Sciences (HCLS) Group and Brad Morrison of the firm’s Industrials Group.

“Larry Gordon, chief executive officer of CCT, and the rest of the CCT management team have built an industry-leading platform that is focused on providing its customers with the best products to uniquely address their specific needs,” said Paul Hepper, managing director at Harris Williams. “CCT’s broad product portfolio and deep industry expertise position the company to capitalize on the tremendous growth in temperature-sensitive pharmaceutical and life sciences products.”

“Through a focus on advanced engineering and technical expertise, CCT continues to develop innovative and differentiated packaging solutions for incredibly demanding applications,” said Brad Morrison, director at Harris Williams. “We can’t wait to watch CCT continue to evolve and accelerate in its next chapter with their new partners.”
According to CCT, with more than 50 years of ensuring product safety in transit, the company has built a reputation as one of the most innovative and reliable providers to the largest global life sciences OEMs and distributors.

Aurora Capital Partners is a leading private equity firm focused principally on control investments in middle-market companies with leading market positions, stable industry dynamics, attractive business model characteristics and actionable opportunities for growth in partnership with management. Aurora claims to provide unique resources to its portfolio companies through its strategy and operations program and its team of experienced operating advisors. Aurora’s investors include leading public and corporate pension funds, endowments and foundations are said to be active in private equity investing.

Harris Williams, an investment bank specializing in M&A advisory services, advocates for sellers and buyers of companies worldwide through critical milestones and provides thoughtful advice during the lives of their businesses. By collaborating as one firm across industry groups and geographies, the firm claims to help its clients achieve outcomes that support their objectives and strategically create value. According to Harris Williams, it is committed to execution excellence and to building enduring, valued relationships that are based on mutual trust. Harris Williams is a subsidiary of the PNC Financial Services Group.